Bristol-Myers Squibb

See the following -

3 Reasons Why Pharma mHealth Apps Have Failed

Jasmine Pennic | HIT Consultant | October 31, 2014

Pharma mHealth companies are struggling to have an impact on the mHealth app market generating only limited downloads and usage, despite releasing more than 100 pharma mHealth apps for iOS and Android...

Read More »

Amazon Digital Health Talent Grab: Box Exec Reportedly Joins Team

Chris Davies | Slash Gear | July 21, 2017

Amazon is quietly building up its digital health tech talent, reportedly poaching a healthcare exec from Box. The Seattle behemoth may be best known for its retail business, but in the background it has a growing footprint in all manner of health technology areas. This latest Amazon talent grab appears to be another move to shore up those...

Read More »

Bristol-Myers Squibb Launches Universal Patient Language (UPL), an Open-Source Resource for Improving Patient Communications

Press Release | Bristol-Myers Squibb | June 16, 2016

The UPL seeks to improve how complex topics are communicated to patients; Company launches UPL.org to make principles and tools widely available to others.  Bristol-Myers Squibb today announced its commitment to moving toward a new way of communicating with patients and caregivers: the Universal Patient Language (UPL). The UPL addresses widely voiced concerns among consumers and health care advocates that communications about medicines are not designed for an optimal patient experience...

Read More »

Conshohocken-Based Non-Profit Aims to Revolutionize Biopharma

T. J. Sharpe | Philly.com | December 1, 2016

What if the next big thing in biopharma wasn’t produced by one of the big pharma companies that line the Northeast corridor between Philadelphia and New York City, but by a whole bunch of them?  Conshohocken-based TransCelerate BioPharma is attempting to accomplish this difficult feat by embracing cooperation instead of competition.  It is a 501(c)3 non-profit consortium of 18 pharmaceutical companies (and growing) that works with the FDA and global regulators to advance the industry through collaboration with researchers, industry organizations, and federal oversight agencies...

Read More »

You Won't Believe the Outrageous Ways Big Pharma Has Bribed Doctors to Shill Drugs

Martha Rosenberg | The Influence | July 18, 2016

At the 2010 meeting of the American Psychiatric Association in New Orleans, a psychiatrist from the East coast shared her anger with me about the recent clamp down on Pharma financial perks to doctors. Before news organizations and the 2010 Physician Financial Transparency Reports (also called the Sunshine Act, part of the Affordable Care Act) reported the outrageous amount of money Pharma was giving doctors to prescribe its new, brand-name drugs, there was almost no limit to what was spent to encourage prescribing...

Read More »